Ownership Positive

2026-05-19 18:23

Acutaas Chemicals Limited announced on May 19, 2026, the preferential allotment of 1,111 equity shares of its subsidiary, Acutaas Chemicals Electrolytes Private Limited (ACEPL), to A.R.Z Pharma Ltd. at an issue price of Rs. 52,490/- per share. This transaction reduces Acutaas Chemicals Limited's shareholding in ACEPL from 100% to 90%, transitioning ACEPL from a wholly-owned subsidiary to a subsidiary. Management control of ACEPL remains unchanged with Acutaas Chemicals Limited.

Business Update Neutral

2026-05-14 18:17

ACUTAAS CHEMICALS LIMITED announced its schedule of investor conferences for May and June 2026. Company officials will attend the 360 ONE Capital (B&K) 16th Annual Investor Conference - Trinity India 2026 in Mumbai on May 27 & 29, and Kotak India Corporate Day events in Hongkong (June 8), Singapore (June 9 & 10), and London (June 15 & 16) to interact with investors/analysts. No price-sensitive information will be discussed.

Routine Neutral

2026-05-06 10:46

New Filing detected. See link for details.

Business Update Neutral

2026-04-30 19:19

ACUTAAS CHEMICALS LIMITED informed the stock exchanges about the availability of the recording for its Earnings Call, which was held on April 30, 2026, at 5:30 p.m. IST. The recording can be accessed on the company's website at www.acutaas.com and through a direct link provided in the filing.

Routine Neutral

2026-04-30 17:38

New Filing detected. See link for details.

Financials Positive

2026-04-30 12:40

Acutaas Chemicals Limited reported strong Q4 FY26 consolidated results. Revenue from Operations stood at ₹4,328mn vs ₹3,085mn (▲40.3% YoY), EBITDA at ₹1,835mn vs ₹850mn (▲116.0% YoY), and PAT at ₹1,343mn vs ₹627mn (▲114.1% YoY). EBITDA Margin expanded significantly to 42.4% vs 27.5% (▲1490bps). Management is confident of delivering 25% revenue growth in FY27.

Financials Positive

2026-04-30 12:25

ACUTAAS CHEMICALS LIMITED (formerly Ami Organics Limited) reported strong consolidated financial results for the quarter ended March 31, 2026. Consolidated Revenue stood at ₹432.75 Cr compared to ₹308.48 Cr in the previous year's corresponding quarter, marking a significant ▲40.26% YoY growth. EBITDA surged to ₹183.51 Cr versus ₹84.96 Cr (▲116.00% YoY), and Net Profit (PAT) increased to ₹134.28 Cr from ₹62.72 Cr (▲114.11% YoY). The company also saw a substantial EBITDA Margin expansion from 27.54% to 42.40% (▲1486 bps). Additionally, the Board recommended a final dividend of ₹2.50 per equity share (50%) for FY 2025-26.

Business Update Neutral

2026-04-27 14:31

Acutaas Chemicals Limited announced an Earnings Conference Call on April 30, 2026, at 5:30 P.M. IST, to discuss the Audited Standalone & Consolidated Financial Results for the fourth quarter and year ended March 31, 2026.

Routine Neutral

2026-04-08 12:10

New Filing detected. See link for details.

Routine Neutral

2026-04-02 18:10

Acutaas Chemicals Limited filed a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent confirmed no dematerialisation requests were received or processed during the quarter.

Routine Neutral

2026-03-25 16:21

Acutaas Chemicals Limited announced the closure of its trading window for designated persons from April 1, 2026, for the purpose of considering the audited financial results for the fourth quarter and year ending March 31, 2026. The window will reopen 48 hours after results declaration.

Business Update Neutral

2026-03-02 12:01

Acutaas Chemicals Limited announced its officials will attend the Investec India Promoter & Founder Conference 2026 on March 11, 2026, in Mumbai. They will engage with investors/analysts in one-on-one or group meetings. No unpublished price-sensitive information will be discussed during the conference.

Business Update Neutral

2026-02-17 12:33

Acutaas Chemicals Limited announced that company officials will attend the Omkara Capital Investors Meet on February 21, 2026, and the Kotak Flagship Conference on February 24, 2026, for one-on-one/group meetings with investors and analysts. No unpublished price-sensitive information will be discussed.

Business Update Positive

2026-02-11 19:03

Acutaas Advance Material Limited, a subsidiary of Acutaas Chemicals Limited, completed the acquisition of a 75% controlling stake in Indichem Inc., a South Korean company in the Semiconductor Chemicals industry. This acquisition aligns with the company's growth strategy to expand its specialty chemicals portfolio.

Business Update Positive

2026-02-03 14:57

Acutaas Chemicals Limited Q3 FY26 Earnings Call transcript confirms strong performance. Revenue just under INR400Cr, PAT over INR100Cr, with YoY growth of 47% in Advanced Pharma and 16.5% in Specialty Chemicals. FY26 revenue growth guidance upgraded to 30%, EBITDA margin to 32-35%. New battery chemicals block inaugurated.

Business Update Neutral

2026-01-30 17:59

Acutaas Chemicals Limited officials will attend the JM Financial India Xchange Conference on February 5, 2026, in Singapore for one-on-one/group meetings with investors/analysts.

Business Update Positive

2026-01-29 18:36

Acutaas Chemicals Limited filed its Annual Sustainability Report for FY 2024-25. The company reported surpassing ₹1,000 crore in consolidated revenue and achieving the EcoVadis Platinum Medal, demonstrating strong financial and sustainability performance.

Financials Positive

2026-01-29 18:21

Consolidated Revenue ₹393.18Cr vs ₹274.99Cr (▲43.0% YoY), EBITDA ₹155.35Cr vs ₹70.34Cr (▲120.9% YoY), PAT ₹106.22Cr vs ₹45.45Cr (▲133.7% YoY). EBITDA Margin 39.5% vs 25.6% (▲1393bps).

ACUTAAS

Acutaas Chemicals Limited

Filing History

Unlock Full History